Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (404)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ibrahim, E. H.
Right arrow Articles by Kollef, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ibrahim, E. H.
Right arrow Articles by Kollef, M. H.
(Chest. 2000;118:146-155.)
© 2000 American College of Chest Physicians

The Influence of Inadequate Antimicrobial Treatment of Bloodstream Infections on Patient Outcomes in the ICU Setting*

Emad H. Ibrahim, MD; Glenda Sherman, RN; Suzanne Ward, RN; Victoria J. Fraser, MD and Marin H. Kollef, MD, FCCP

* From the Divisions of Pulmonary and Critical Care Medicine (Drs. Ibrahim and Kollef and Ms. Ward) and Infectious Diseases (Dr. Fraser), Department of Internal Medicine, Washington University School of Medicine, and the Department of Nursing (Ms. Sherman), Barnes-Jewish Hospital, Saint Louis, MO.

Correspondence to: Marin H. Kollef, MD, FCCP, Pulmonary and Critical Care Medicine, Washington University School of Medicine, Campus Box 8052, 660 S. Euclid Ave., St. Louis, MO 63110; e-mail: mkollef{at}pulmonary.wustl.edu

Study objective: To evaluate the relationship between the adequacy of antimicrobial treatment for bloodstream infections and clinical outcomes among patients requiring ICU admission.

Design: Prospective cohort study.

Setting: A medical ICU (19 beds) and a surgical ICU (18 beds) from a university-affiliated urban teaching hospital.

Patients: Between July 1997 and July 1999, 492 patients were prospectively evaluated.

Intervention: Prospective patient surveillance and data collection.

Results: One hundred forty-seven patients (29.9%) received inadequate antimicrobial treatment for their bloodstream infections. The hospital mortality rate of patients with a bloodstream infection receiving inadequate antimicrobial treatment (61.9%) was statistically greater than the hospital mortality rate of patients with a bloodstream infection who received adequate antimicrobial treatment (28.4%; relative risk, 2.18; 95% confidence interval [CI], 1.77 to 2.69; p < 0.001). Multiple logistic regression analysis identified the administration of inadequate antimicrobial treatment as an independent determinant of hospital mortality (adjusted odds ratio [AOR], 6.86; 95% CI, 5.09 to 9.24; p < 0.001). The most commonly identified bloodstream pathogens and their associated rates of inadequate antimicrobial treatment included vancomycin-resistant enterococci (n = 17; 100%), Candida species (n = 41; 95.1%), oxacillin-resistant Staphylococcus aureus (n = 46; 32.6%), coagulase-negative staphylococci (n = 96; 21.9%), and Pseudomonas aeruginosa (n = 22; 10.0%). A statistically significant relationship was found between the rates of inadequate antimicrobial treatment for individual microorganisms and their associated rates of hospital mortality (Spearman correlation coefficient = 0.8287; p = 0.006). Multiple logistic regression analysis also demonstrated that a bloodstream infection attributed to Candida species (AOR, 51.86; 95% CI, 24.57 to 109.49; p < 0.001), prior administration of antibiotics during the same hospitalization (AOR, 2.08; 95% CI, 1.58 to 2.74; p = 0.008), decreasing serum albumin concentrations (1-g/dL decrements) (AOR, 1.37; 95% CI, 1.21 to 1.56; p = 0.014), and increasing central catheter duration (1-day increments) (AOR, 1.03; 95% CI, 1.02 to 1.04; p = 0.008) were independently associated with the administration of inadequate antimicrobial treatment.

Conclusions: The administration of inadequate antimicrobial treatment to critically ill patients with bloodstream infections is associated with a greater hospital mortality compared with adequate antimicrobial treatment of bloodstream infections. These data suggest that clinical efforts should be aimed at reducing the administration of inadequate antimicrobial treatment to hospitalized patients with bloodstream infections, especially individuals infected with antibiotic-resistant bacteria and Candida species.

Key Words: antibiotics • bacteremia • bloodstream infections • Candida species • enterococci • intensive care • outcomes • resistance • Staphylococcus aureus




This article has been cited by other articles:


Home page
ChestHome page
C.-H. Chen, W.-H. Hsu, H.-J. Chen, W. Chen, C.-M. Shih, T.-C. Hsia, and C.-Y. Tu
Different Bacteriology and Prognosis of Thoracic Empyemas Between Patients With Chronic and End-Stage Renal Disease
Chest, August 1, 2007; 132(2): 532 - 539.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. H. Kollef
Diagnosis of Ventilator-Associated Pneumonia
N. Engl. J. Med., December 21, 2006; 355(25): 2691 - 2693.
[Full Text] [PDF]


Home page
NEJMHome page
J. A. Russell
Management of Sepsis
N. Engl. J. Med., October 19, 2006; 355(16): 1699 - 1713.
[Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
K. K. Scarsi, J. M. Feinglass, M. H. Scheetz, M. J. Postelnick, M. K. Bolon, and G. A. Noskin
Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay.
Antimicrob. Agents Chemother., October 1, 2006; 50(10): 3355 - 3360.
[Abstract] [Full Text] [PDF]


Home page
Emerg. Med. J.Home page
P A Nee
Critical care in the emergency department: severe sepsis and septic shock.
Emerg. Med. J., September 1, 2006; 23(9): 713 - 717.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
S. J. Albrecht, N. O. Fishman, J. Kitchen, I. Nachamkin, W. B. Bilker, C. Hoegg, C. Samel, S. Barbagallo, J. Arentzen, and E. Lautenbach
Reemergence of Gram-negative Health Care-Associated Bloodstream Infections.
Arch Intern Med, June 26, 2006; 166(12): 1289 - 1294.
[Abstract] [Full Text] [PDF]


Home page
Int J Qual Health CareHome page
K. A. Thursky, K. L. Buising, N. Bak, L. Macgregor, A. C. Street, C. R. Macintyre, J. J. Presneill, J. F. Cade, and G. V. Brown
Reduction of broad-spectrum antibiotic use with computerized decision support in an intensive care unit
Int. J. Qual. Health Care, June 1, 2006; 18(3): 224 - 231.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
R. H. Drew, K. Kawamoto, and M. B. Adams
Information technology for optimizing the management of infectious diseases
Am. J. Health Syst. Pharm., May 15, 2006; 63(10): 957 - 965.
[Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
D. J. Anderson, J. J. Engemann, L. J. Harrell, Y. Carmeli, L. B. Reller, and K. S. Kaye
Predictors of Mortality in Patients with Bloodstream Infection Due to Ceftazidime-Resistant Klebsiella pneumoniae.
Antimicrob. Agents Chemother., May 1, 2006; 50(5): 1715 - 1720.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
R. P. H. Peters, P. H. M. Savelkoul, A. M. Simoons-Smit, S. A. Danner, C. M. J. E. Vandenbroucke-Grauls, and M. A. van Agtmael
Faster Identification of Pathogens in Positive Blood Cultures by Fluorescence In Situ Hybridization in Routine Practice
J. Clin. Microbiol., January 1, 2006; 44(1): 119 - 123.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
K. Kanemitsu, H. Kunishima, M. Hatta, K. Inden, T. Saga, H. Ouchi, K. Ishizawa, H. Harigae, H. Takemura, and M. Kaku
Evaluation of a Fully Automated System (RAISUS) for Rapid Identification and Antimicrobial Susceptibility Testing of Staphylococci
J. Clin. Microbiol., November 1, 2005; 43(11): 5808 - 5810.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
G Barlow and D Nathwani
Is antibiotic resistance a problem? A practical guide for hospital clinicians
Postgrad. Med. J., November 1, 2005; 81(961): 680 - 692.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
C. MacDougall and R. E. Polk
Antimicrobial Stewardship Programs in Health Care Systems
Clin. Microbiol. Rev., October 1, 2005; 18(4): 638 - 656.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
M. I. Rudis and K. L. Rowland
Current Concepts in Severe Sepsis and Septic Shock
Journal of Pharmacy Practice, October 1, 2005; 18(5): 351 - 362.
[Abstract] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. Morrell, V. J. Fraser, and M. H. Kollef
Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality
Antimicrob. Agents Chemother., September 1, 2005; 49(9): 3640 - 3645.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
P. M. G. Filius, I. C. Gyssens, I. M. Kershof, P. J. E. Roovers, A. Ott, A. G. Vulto, H. A. Verbrugh, and H. P. Endtz
Colonization and Resistance Dynamics of Gram-Negative Bacteria in Patients during and after Hospitalization
Antimicrob. Agents Chemother., July 1, 2005; 49(7): 2879 - 2886.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. Povoa, L. Coelho, E. Almeida, A. Fernandes, R. Mealha, P. Moreira, and H. Sabino
C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study
Eur. Respir. J., May 1, 2005; 25(5): 804 - 812.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. T. Micek, A. E. Lloyd, D. J. Ritchie, R. M. Reichley, V. J. Fraser, and M. H. Kollef
Pseudomonas aeruginosa Bloodstream Infection: Importance of Appropriate Initial Antimicrobial Treatment
Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1306 - 1311.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
A. Thiolas, C. Bollet, B. La Scola, D. Raoult, and J.-M. Pages
Successive Emergence of Enterobacter aerogenes Strains Resistant to Imipenem and Colistin in a Patient
Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1354 - 1358.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
G. P. Patel and C. W. Crank
Gram-Negative Resistance in the Intensive Care Unit
Journal of Pharmacy Practice, April 1, 2005; 18(2): 91 - 99.
[Abstract] [PDF]


Home page
Am J Health Syst PharmHome page
J. W. Wilson, L. J. Oyen, N. N. Ou, M. M. McMahon, R. L. Thompson, J. M. Manahan, K. K. Graner, J. K. Lovely, and L. L. Estes
Hospital rules-based system: The next generation of medical informatics for patient safety
Am. J. Health Syst. Pharm., March 1, 2005; 62(5): 499 - 505.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia
Am. J. Respir. Crit. Care Med., February 15, 2005; 171(4): 388 - 416.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
J. R. McDonald, N. D. Friedman, J. E. Stout, D. J. Sexton, and K. S. Kaye
Risk Factors for Ineffective Therapy in Patients With Bloodstream Infection
Arch Intern Med, February 14, 2005; 165(3): 308 - 313.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
C.-I. Kang, S.-H. Kim, W. B. Park, K.-D. Lee, H.-B. Kim, E.-C. Kim, M.-d. Oh, and K.-W. Choe
Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome
Antimicrob. Agents Chemother., February 1, 2005; 49(2): 760 - 766.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. D. Obritsch, D. N. Fish, R. MacLaren, and R. Jung
National Surveillance of Antimicrobial Resistance in Pseudomonas aeruginosa Isolates Obtained from Intensive Care Unit Patients from 1993 to 2002
Antimicrob. Agents Chemother., December 1, 2004; 48(12): 4606 - 4610.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
J. J. De Waele, D. Vogelaers, E. Hoste, S. Blot, and F. Colardyn
Emergence of Antibiotic Resistance in Infected Pancreatic Necrosis
Arch Surg, December 1, 2004; 139(12): 1371 - 1375.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
A. Corona, A. P. R. Wilson, M. Grassi, and M. Singer
Prospective audit of bacteraemia management in a university hospital ICU using a general strategy of short-course monotherapy
J. Antimicrob. Chemother., October 1, 2004; 54(4): 809 - 817.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
S.-H. Kim, W.-B. Park, K.-D. Lee, C.-I. Kang, J.-W. Bang, H.-B. Kim, E.-C. Kim, M.-d. Oh, and K.-W. Choe
Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia
J. Antimicrob. Chemother., August 1, 2004; 54(2): 489 - 497.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. D. Carrigan, G. Scott, and M. Tabrizian
Toward Resolving the Challenges of Sepsis Diagnosis
Clin. Chem., August 1, 2004; 50(8): 1301 - 1314.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Med. Inform. Assoc.Home page
J. S. Sellman, D. Decarolis, A. Schullo-Feulner, D. B. Nelson, and G. A. Filice
Information Resources Used in Antimicrobial Prescribing
J. Am. Med. Inform. Assoc., July 1, 2004; 11(4): 281 - 284.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
R. Reynolds, N. Potz, M. Colman, A. Williams, D. Livermore, A. MacGowan, and on behalf of the BSAC Extended Working Party on Ba
Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme
J. Antimicrob. Chemother., June 1, 2004; 53(6): 1018 - 1032.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
B. Afessa
From "Pro and Con" Debate to Evidence-Based Practice: Ventilator-Associated Pneumonia
Chest, May 1, 2004; 125(5): 1600 - 1602.
[Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
S. Klaschik, L. E. Lehmann, A. Raadts, M. Book, J. Gebel, A. Hoeft, and F. Stuber
Detection and Differentiation of In Vitro-Spiked Bacteria by Real-Time PCR and Melting-Curve Analysis
J. Clin. Microbiol., February 1, 2004; 42(2): 512 - 517.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Osmon, S. Ward, V. J. Fraser, and M. H. Kollef
Hospital Mortality for Patients With Bacteremia Due to Staphylococcus aureus or Pseudomonas aeruginosa
Chest, February 1, 2004; 125(2): 607 - 616.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. A. J. Hoste, S. I. Blot, N. H. Lameire, R. C. Vanholder, D. De Bacquer, and F. A. Colardyn
Effect of Nosocomial Bloodstream Infection on the Outcome of Critically Ill Patients with Acute Renal Failure Treated with Renal Replacement Therapy
J. Am. Soc. Nephrol., February 1, 2004; 15(2): 454 - 462.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
A. Corona, G. Bertolini, A. M. Ricotta, A. J. P. Wilson, and M. Singer
Variability of treatment duration for bacteraemia in the critically ill: a multinational survey
J. Antimicrob. Chemother., November 1, 2003; 52(5): 849 - 852.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
R. P. Wenzel, D. F. Sahm, C. Thornsberry, D. C. Draghi, M. E. Jones, and J. A. Karlowsky
In Vitro Susceptibilities of Gram-Negative Bacteria Isolated from Hospitalized Patients in Four European Countries, Canada, and the United States in 2000-2001 to Expanded-Spectrum Cephalosporins and Comparator Antimicrobials: Implications for Therapy
Antimicrob. Agents Chemother., October 1, 2003; 47(10): 3089 - 3098.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
S. A. Zelenitsky, G. K. M. Harding, S. Sun, K. Ubhi, and R. E. Ariano
Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis
J. Antimicrob. Chemother., October 1, 2003; 52(4): 668 - 674.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
E. Chamot, E. Boffi El Amari, P. Rohner, and C. Van Delden
Effectiveness of Combination Antimicrobial Therapy for Pseudomonas aeruginosa Bacteremia
Antimicrob. Agents Chemother., September 1, 2003; 47(9): 2756 - 2764.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. Valles, J. Rello, A. Ochagavia, J. Garnacho, and M. A. Alcala
Community-Acquired Bloodstream Infection in Critically Ill Adult Patients: Impact of Shock and Inappropriate Antibiotic Therapy on Survival
Chest, May 1, 2003; 123(5): 1615 - 1624.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. I. Blot, K. H. Vandewoude, and F. A. Colardyn
Evaluation of Outcome in Critically Ill Patients With Nosocomial Enterobacter Bacteremia: Results of a Matched Cohort Study
Chest, April 1, 2003; 123(4): 1208 - 1213.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
K. Maquelin, C. Kirschner, L.-P. Choo-Smith, N. A. Ngo-Thi, T. van Vreeswijk, M. Stammler, H. P. Endtz, H. A. Bruining, D. Naumann, and G. J. Puppels
Prospective Study of the Performance of Vibrational Spectroscopies for Rapid Identification of Bacterial and Fungal Pathogens Recovered from Blood Cultures
J. Clin. Microbiol., January 1, 2003; 41(1): 324 - 329.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
A. H Mutnick, J. T Kirby, and R. N Jones
CANCER Resistance Surveillance Program: Initial Results from Hematology-Oncology Centers in North America
Ann. Pharmacother., January 1, 2003; 37(1): 47 - 56.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
S. Harbarth, K. Ferriere, S. Hugonnet, B. Ricou, P. Suter, and D. Pittet
Epidemiology and Prognostic Determinants of Bloodstream Infections in Surgical Intensive Care
Arch Surg, December 1, 2002; 137(12): 1353 - 1359.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. L. Gerberding
Hospital-Onset Infections: A Patient Safety Issue
Ann Intern Med, October 15, 2002; 137(8): 665 - 670.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Iregui, S. Ward, G. Sherman, V. J. Fraser, and M. H. Kollef
Clinical Importance of Delays in the Initiation of Appropriate Antibiotic Treatment for Ventilator-Associated Pneumonia*
Chest, July 1, 2002; 122(1): 262 - 268.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
L. Steinstraesser, B. F. Tack, A. J. Waring, T. Hong, L. M. Boo, M.-H. Fan, D. I. Remick, G. L. Su, R. I. Lehrer, and S. C. Wang
Activity of Novispirin G10 against Pseudomonas aeruginosa In Vitro and in Infected Burns
Antimicrob. Agents Chemother., June 1, 2002; 46(6): 1837 - 1844.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
K. Maquelin, L.-P. Choo-Smith, H. P. Endtz, H. A. Bruining, and G. J. Puppels
Rapid Identification of Candida Species by Confocal Raman Microspectroscopy
J. Clin. Microbiol., February 1, 2002; 40(2): 594 - 600.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
T. Y. Tan, S. Corden, R. Barnes, and B. Cookson
Rapid Identification of Methicillin-Resistant Staphylococcus aureus from Positive Blood Cultures by Real-Time Fluorescence PCR
J. Clin. Microbiol., December 1, 2001; 39(12): 4529 - 4531.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. Brun-Buisson and F. Lemaire
Administration of Antibiotics for Pneumonia during Respiratory Failure: Reaching the Target
Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1554 - 1555.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. BRUN-BUISSON
New Technologies and Infection Control Practices to Prevent Intravascular Catheter-related Infections
Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1557 - 1558.
[Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
L. Leibovici, R. Berger, T. Gruenewald, J. Yahav, Y. Yehezkelli, G. Milo, M. Paul, Z. Samra, and S. D. Pitlik
Departmental consumption of antibiotic drugs and subsequent resistance: a quantitative link
J. Antimicrob. Chemother., October 1, 2001; 48(4): 535 - 540.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. Rello, J. A. Paiva, J. Baraibar, F. Barcenilla, M. Bodi, D. Castander, H. Correa, E. Diaz, J. Garnacho, M. Llorio, et al.
International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-Associated Pneumonia
Chest, September 1, 2001; 120(3): 955 - 970.
[Abstract] [Full Text] [PDF]


Home page
JWatch Infect. DiseasesHome page
Inadequate Antimicrobial Treatment of Bacteremia Is Harmful
Journal Watch Infectious Diseases, October 5, 2000; 2000(1005): 9 - 9.
[Full Text]


Home page
JWatch Emergency Med.Home page
Inadequate Antibiotic Therapy in Critically Ill Patients Increases Mortality
Journal Watch Emergency Medicine, September 19, 2000; 2000(919): 9 - 9.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American College of Chest Physicians.